A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis | Zendy

Beatriz Pozuelo Moyano | Zendy; Julián BenitoLeón | Zendy; Alex J. Mitchell | Zendy; Jesús HernándezGallego | Zendy

Open Access

A Systematic Review of Randomized, Double-Blind, Placebo-Controlled Trials Examining the Clinical Efficacy of Vitamin D in Multiple Sclerosis

Author(s) -

Beatriz Pozuelo Moyano,

Julián BenitoLeón,

Alex J. Mitchell,

Jesús HernándezGallego

Publication year - 2012

Publication title -

neuroepidemiology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.217

H-Index - 87

eISSN - 1423-0208

pISSN - 0251-5350

DOI - 10.1159/000345122

Subject(s) - medicine , jadad scale , placebo , adverse effect , vitamin d and neurology , clinical trial , randomized controlled trial , vitamin , gastroenterology , multiple sclerosis , pathology , immunology , alternative medicine , cochrane library

An association between multiple sclerosis (MS) prevalence as well as MS mortality and vitamin D nutrition has led to the hypothesis that high levels of vitamin D could be beneficial for MS. The purpose of this systematic review is to establish whether there is evidence for or against vitamin D in the treatment of MS.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research